Opinion on the Ethical Aspects of Umbilical Cord Blood Banking PDF Download

Author: European Group on Ethics in Science and New Technologies to the European Commission
Publisher:
ISBN:
Category : Banques de sang de cordon ombilical
Languages : de
Pages : 192

View

Book Description

Author: Lisandra Vanostrand
Publisher: Nova Science Publishers
ISBN: 9781626180727
Category : Blood banks
Languages : en
Pages : 0

View

Book Description
In this book, the authors discuss cord blood banks and banking, the ethical issues involved and the risks and benefits. Topics include the virological risks and benefits of cord blood banking; mesenchymal stem cells and their role in regenerative medicine applications; osteogenic potential of human umbilical cord-derived mesenchymal stromal cells; public versus private cord blood banking; CCR5 deficient cord blood as a means of treatment for HIV-1 infection; and the therapeutic use of umbilical cord blood.

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309095867
Category : Medical
Languages : en
Pages : 335

View

Book Description
With the potential for self-renewal and differentiation, the possibilities for stem cells are enormous. One specific type of stem cell, the hematopoietic progenitor cell (HPC), which is derived from umbilical cord blood (as well as adult bone marrow and mobilized peripheral blood), holds particular promise. To make the most of these HPCs, the Institute of Medicine was asked to consider the optimal structure for a national cord blood program and to address pertinent issues related to maximizing the potential of stem cell technology. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program examines: The role of cord blood in stem cell transplantation The current status of blood banks already in existence The optimal structure for the cord blood program The current use and utility of cord blood for stem cell transplants The best way to advance the use of cord blood units and make them available for research Expert advice from leaders in the fields of economics, public health, medicine, and biostatistics combine to make this very timely and topical book useful to a number of stakeholders.

Author: Johnson, Angela Christine
Publisher: Ann Arbor, Mich. : University Microfilms International
ISBN:
Category : Fetal blood
Languages : en
Pages : 48

View

Book Description

Author: Jeremy Sugarman
Publisher:
ISBN:
Category :
Languages : en
Pages :

View

Book Description

Author: Colin R. Macpherson
Publisher: American Association of Blood Banks (AABB)
ISBN:
Category : Blood
Languages : en
Pages : 196

View

Book Description

Author: Karen Devine
Publisher: Taylor & Francis
ISBN: 1317555457
Category : Law
Languages : en
Pages : 224

View

Book Description
Since the therapeutic value of umbilical cord blood (UCB) stem cells was first recognised in the late 1980s, there has been a proliferation of both public and private UCB banks worldwide. However, the ability to utilise such a potentially valuable resource has provoked a number of controversies. In a distinctly accessible style, this book unpacks the socio-legal implications of the UCB collection process and constructs a detailed analysis of the law and ethics that surrounds UCB banking in the UK, including ownership of the cells. Its enquiry is located within the theoretical framework of altruism versus self-interest and explores the notions of risk and choice associated with this distinctive blend of public/private healthcare provision. The book evaluates the impact of the Human Tissue Act 2004 and the European Union Tissues and Cells Directive (2004/23/EC) on the UCB industry and provides a unique insight into the effect that the law may have on the NHS whose maternity staff and premises are used to collect UCB. This book would be of interest primarily to a UK readership in addition to expectant families, health professionals, students, academics, practitioners and the UCB industry elsewhere in the world.

Author: Rachel Inbar
Publisher:
ISBN: 9781549631597
Category :
Languages : en
Pages : 38

View

Book Description
You're expecting a baby. A whole new human being who completely depends on you to do everything possible to give her or him the best chance at life. You've carefully chosen the safest car seat, the crib with the best reviews and are determined that your baby be breastfed... so, how could you not use the single opportunity you have to bank his or her cord blood too? I mean, what if 10 years down the line your child has an illness that can be cured using it - and you didn't bank. How are you going to feel then? This paper, written as a seminar paper for a business ethics course, cites over 40 sources, with the goal of exploring the ethical aspects of commercial cord blood banking. The paper begins with an overview of what cord blood is, its status (is it medical waste or a valuable treasure?), its possible uses, alternatives to use of autologous cord blood (cord blood from the patient herself), and likelihood of use. It goes on to discuss ethical aspects using guidelines of medical ethics, Kant's Categorical Imperative and Rawl's Theory of Justice - and how commercial cord blood banking complies and does not comply to each. It discusses ethical questions that arise, including the effects of manipulative advertising on informed consent and the exploitation of vulnerability. The paper concludes with a clear conclusion that will help any parent make the informed decision s/he could not make without having the information presented here - a decision that can be made with no regrets or second thoughts. The writer of the paper was highly commended for her comprehensive approach the topic and awarded the grade of 99.

Author:
Publisher:
ISBN: 9783843328845
Category :
Languages : en
Pages : 0

View

Book Description

Author: Ana Colette Maurício
Publisher: BoD – Books on Demand
ISBN: 9535128655
Category : Science
Languages : en
Pages : 260

View

Book Description
Umbilical cord blood (UCB) and, more recently, umbilical cord tissue (UCT) have been stored cryopreserved in private and public cord blood and tissue banks worldwide, since the umbilical cord blood was used for the first time in a child with Fanconi anemia with his HLA-identical sibling, following strict guidelines that imply high-quality standards and total rastreability of these units. The hematopoietic stem cells (HSCs) are clinically used in hematopoietic treatments for blood disorders and hemato-oncological diseases. Also, the mesenchymal stem cells (MSCs) isolated from the UCT and UCB, nowadays, can be used as coadjuvants of hematopoietic transplants. In the near future, these stem cells will have a crucial role in regenerative medicine. For this reason, these cells have been tested in several clinical trials and compassive treatments in children and adults, concerning a wide range of pathologies and diseases, for instance, for the treatment of cerebral paralysis. Considering the worldwide availability of UCB and UCT units and the absence of ethical concerns will probably become the best sources for cell-based therapies for hematological and nonhematological pathologies. The UCB will also have a crucial role in neonatology-predictive analysis in the near future.